These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8499043)

  • 21. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder.
    Sebrechts MM; Shaywitz SE; Shaywitz BA; Jatlow P; Anderson GM; Cohen DJ
    Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial.
    Konrad K; Günther T; Heinzel-Gutenbrunner M; Herpertz-Dahlmann B
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):180-90. PubMed ID: 15910203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ineffectiveness of imipramine in children who fail to respond to methylphenidate.
    Winsberg BG; Kupietz SS; Yepes LE; Goldstein S
    J Autism Dev Disord; 1980 Jun; 10(2):129-37. PubMed ID: 6765502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
    Turner DC; Blackwell AD; Dowson JH; McLean A; Sahakian BJ
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):286-95. PubMed ID: 15338103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A divided attention analysis of the effects of methylphenidate on the arithmetic performance of children with attention-deficit hyperactivity disorder.
    Carlson CL; Pelham WE; Swanson JM; Wagner JL
    J Child Psychol Psychiatry; 1991 Mar; 32(3):463-71. PubMed ID: 2061366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of clinical response in children taking methylphenidate.
    Aman MG; Turbott SH
    J Autism Dev Disord; 1991 Jun; 21(2):211-28. PubMed ID: 1864828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI
    Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance.
    Johnston C; Fine S
    J Pediatr Psychol; 1993 Dec; 18(6):717-30. PubMed ID: 8138866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate.
    Hinshaw SP; Heller T; McHale JP
    J Consult Clin Psychol; 1992 Apr; 60(2):274-281. PubMed ID: 1592958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responders, nonresponders, and placebo responders among children with attention deficit disorder. Importance of a blinded placebo evaluation.
    Ullmann RK; Sleator EK
    Clin Pediatr (Phila); 1986 Dec; 25(12):594-9. PubMed ID: 3536258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects.
    Aman MG; Kern RA; McGhee DE; Arnold LE
    J Autism Dev Disord; 1993 Sep; 23(3):491-506. PubMed ID: 8226583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders.
    Ter-Stepanian M; Grizenko N; Zappitelli M; Joober R
    Can J Psychiatry; 2010 May; 55(5):305-12. PubMed ID: 20482957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a reanalysis using drug-placebo and drug-drug response curve methodology.
    Faraone SV; Pliszka SR; Olvera RL; Skolnik R; Biederman J
    J Child Adolesc Psychopharmacol; 2001; 11(2):171-80. PubMed ID: 11436957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.
    Verster JC; Roth T
    J Clin Psychopharmacol; 2014 Oct; 34(5):633-6. PubMed ID: 24978156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance.
    Aman MG; Marks RE; Turbott SH; Wilsher CP; Merry SN
    J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):816-24. PubMed ID: 1938800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate v. placebo--a randomised double-blind crossover study in children with the attention deficit disorder.
    Cotton MF; Rothberg AD
    S Afr Med J; 1988 Sep; 74(6):268-71. PubMed ID: 3047886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.